ScholarIQanswers from OpenAlex

Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury

PaperCitations, authors & open-access status

Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury have?

ScholarIQcitation count

Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury has 116 citations in the OpenAlex counts ScholarIQ stores.

When was Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury published?

ScholarIQyear

Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury has 2018 year in the ScholarIQ index.

What is the open-access status of Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury?

ScholarIQoa status

Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury has hybrid oa status in the ScholarIQ index.

What is the DOI of Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury?

ScholarIQdoi

The DOI for Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury is on the source record.

What is the PMID of Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury?

ScholarIQpmid

The PMID for Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury is on the source record.

What is the OpenAlex record for Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury?

ScholarIQopenalex

The OpenAlex for Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial